Learn About Tongue Cancer

What is the definition of Tongue Cancer?
Tongue (oral) cancer can occur in different areas of the oral cavity, such as on the surface of the tongue in the mouth, or at the base of the tongue in the throat. Causes of tongue cancer include tobacco and heavy alcohol use, a weakened immune system, infection with the human papillomavirus (HPV) or a previous history of head and neck cancer. The risk of tongue cancer is higher in males. In time tongue cancers may spread to other areas of the mouth, head, and neck. Most oral cancers are squamous cell carcinomas.
Save information for later
Sign Up
What are the symptoms of Tongue Cancer?
Signs and symptoms of tongue (oral) cancer include white or red patches, a sore that will not heal, bleeding, problems with pain when swallowing, a neck or mouth lump, trouble chewing, swallowing, or moving the tongue or jaw, jaw swelling, or a sore throat.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Tongue Cancer?
Treatment is determined by the type of tongue cancer cells and may include surgery, radiation therapy, chemotherapy, or a combination.
Who are the top Tongue Cancer Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Tongue Cancer Clinical Trials?
Phase I/II Study of M7824 Plus Curative Intent Re-Irradiation With Stereotactic Body Radiation Therapy (SBRT) in Patients With Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma
Summary: This phase I/II trial studies the side effects and how well bintrafusp alfa and stereotactic body radiation therapy work in treating patients with head and neck squamous cell cancer that has come back (recurrent) or has occurred after having cancer in the past (second primary). Immunotherapy with bintrafusp alfa may induce changes in body's immune system and may interfere with the ability of tumor...
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II, Open-Label, Single-arm Study of Toripalimab As Consolidation Therapy After Postoperative Radiotherapy or Chemoradiotherapy in Patients With Head and Neck Squamous Cell Carcinomas (HNSCC)
Summary: This study is a phase II, open label, single-arm and exploratory clinical trial. The purpose of this study is to observe the efficacy and safety of consolidation immunotherapy with Toripalimab following postoperative radiotherapy or chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinomas (HNSCC).
What are the Latest Advances for Tongue Cancer?
Effect of three tongue needles acupoints Lianquan (CV23) and Hegu (LI4) combined with swallowing training on the quality of life of laryngeal cancer patients with dysphagia after surgery.
Summary: Effect of three tongue needles acupoints Lianquan (CV23) and Hegu (LI4) combined with swallowing training on the quality of life of laryngeal cancer patients with dysphagia after surgery.
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
Summary: Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
Tired of the same old research?
Check Latest Advances
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.
Summary: Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.